Your browser doesn't support javascript.
loading
A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients.
Stodtmann, Sven; Nuthalapati, Silpa; Eckert, Doerthe; Kasichayanula, Sreeneeranj; Joshi, Rujuta; Bach, Bruce A; Mensing, Sven; Menon, Rajeev; Xiong, Hao.
Afiliación
  • Stodtmann S; Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.
  • Nuthalapati S; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois, USA.
  • Eckert D; Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.
  • Kasichayanula S; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois, USA.
  • Joshi R; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois, USA.
  • Bach BA; Oncology Development, AbbVie Inc, North Chicago, Illinois, USA.
  • Mensing S; Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.
  • Menon R; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois, USA.
  • Xiong H; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois, USA.
J Clin Pharmacol ; 61(9): 1195-1205, 2021 09.
Article en En | MEDLINE | ID: mdl-33894017

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bencimidazoles / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bencimidazoles / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Alemania